Guangdong Transtek Medical Electronics Co., Ltd
Shenzhen Stock ExchangeTotal Valuation
Guangdong Transtek Medical Electronics Co., Ltd carries a market capitalization of 3.19B, placing it among publicly traded companies globally. Its enterprise value stands at 2.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.19B |
| Enterprise Value | 2.47B |
Share Statistics
Guangdong Transtek Medical Electronics Co., Ltd currently has 217.57M shares outstanding.
| Shares Outstanding | 217.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Guangdong Transtek Medical Electronics Co., Ltd trades at a trailing price-to-earnings ratio of 44.71. The price-to-sales ratio is 3.06, and the price-to-book ratio stands at 6.80.
| PE Ratio | 44.71 |
| PS Ratio | 3.06 |
| PB Ratio | 6.80 |
| P/TBV Ratio | 3.35 |
| P/FCF Ratio | 107.55 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Guangdong Transtek Medical Electronics Co., Ltd trades at an EV/EBITDA multiple of 31.36 and an EV/FCF ratio of 73.36. The EV/Sales ratio of 2.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.45 |
| EV / EBITDA | 31.36 |
| EV / EBIT | 31.36 |
| EV / FCF | 73.36 |
Financial Position
Guangdong Transtek Medical Electronics Co., Ltd maintains a current ratio of 2.16, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.01, indicating elevated leverage, while an interest coverage ratio of 14.89 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.16 |
| Quick Ratio | 1.54 |
| Debt / Equity | 15.01 |
| Debt / EBITDA | 1.89 |
| Interest Coverage | 14.89 |
Financial Efficiency
Guangdong Transtek Medical Electronics Co., Ltd posts a return on equity of 15.24 and a return on invested capital of 6.50.
| Return on Equity (ROE) | 15.24 |
| Return on Assets (ROA) | 4.48 |
| Return on Invested Capital (ROIC) | 6.50 |
| Return on Capital Employed (ROCE) | 12.82 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.96 |
Taxes
Over the trailing twelve months, Guangdong Transtek Medical Electronics Co., Ltd has paid 3.30M in income taxes, reflecting an effective tax rate of 4.73.
| Income Tax | 3.30M |
| Effective Tax Rate | 4.73 |
Stock Price Statistics
Guangdong Transtek Medical Electronics Co., Ltd's stock has declined approximately -7.78481% over the past 52 weeks. The 50-day moving average sits at 13.20, while the 200-day moving average is 13.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | -7.78481% |
| 50-Day Moving Average | 13.20 |
| 200-Day Moving Average | 13.87 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Guangdong Transtek Medical Electronics Co., Ltd generated 1.01B in revenue and converted that into 68.80M in net income, yielding earnings per share of 0.32. EBITDA reached 78.68M, while operating income came in at 78.68M.
| Revenue | 1.01B |
| Gross Profit | 345.10M |
| Operating Income | 78.68M |
| Pretax Income | 69.81M |
| Net Income | 68.80M |
| EBITDA | 78.68M |
| EBIT | 78.68M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
Guangdong Transtek Medical Electronics Co., Ltd holds 736.46M in cash and equivalents against 148.47M in total debt, resulting in a net debt position of -594.61M. Total book value stands at 452.09M, with working capital of 553.77M providing operational flexibility.
| Cash & Cash Equivalents | 736.46M |
| Total Debt | 148.47M |
| Net Debt | -594.61M |
| Equity (Book Value) | 452.09M |
| Book Value Per Share | 2.17 |
| Working Capital | 553.77M |
Cash Flow
After subtracting -28.60M in capital expenditures, free cash flow totaled -28.60M - equivalent to -0.14 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -28.60M |
| Free Cash Flow | -28.60M |
| FCF Per Share | -0.14 |
Margins
Guangdong Transtek Medical Electronics Co., Ltd operates with a gross margin of 34.28, reflecting its pricing power and cost economics. The operating margin of 7.82 and net profit margin of 6.83 provide insight into operational efficiency.
| Gross Margin | 34.28 |
| Operating Margin | 7.82 |
| Pretax Margin | 6.93 |
| Profit Margin | 6.83 |
| EBITDA Margin | 7.82 |
Dividends & Yields
The company's payout ratio of 103.29 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.32 |
| Dividend Yield | N/A |
| Payout Ratio | 103.29 |
| Shareholder Yield | 2.97 |
| FCF Yield | 0.93 |
Stock Splits
Guangdong Transtek Medical Electronics Co., Ltd's most recent stock split took place on April 18, 2017 with a 5:16 split ratio.
| Last Split Date | 4/18/2017 |
| Split Ratio | 5:16 |
Scores
Guangdong Transtek Medical Electronics Co., Ltd posts an Altman Z-Score of 5.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.34 |